Advaxis, Inc.
(NASDAQ : ADXS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
-0.69%342.851.2%$619.74m
GILDGilead Sciences, Inc.
-0.67%72.430.9%$507.28m
CELGCelgene Corporation
-0.43%89.981.2%$494.26m
AMGNAmgen Inc.
-0.10%197.231.2%$484.87m
ILMNIllumina, Inc.
0.24%326.673.5%$374.60m
REGNRegeneron Pharmaceuticals, Inc.
-0.41%372.742.6%$314.50m
VRTXVertex Pharmaceuticals Incorporated
-0.90%174.501.9%$207.20m
ALXNAlexion Pharmaceuticals, Inc.
0.18%116.212.0%$186.92m
AAgilent Technologies, Inc.
0.09%64.721.5%$159.42m
SRPTSarepta Therapeutics, Inc.
-0.18%130.0216.6%$142.21m
NKTRNektar Therapeutics
0.42%60.285.6%$126.81m
BLUEBluebird Bio, Inc.
-0.73%156.8514.6%$120.69m
EXASExact Sciences Corporation
-0.80%48.4525.3%$117.87m
BMRNBioMarin Pharmaceutical Inc.
-2.01%98.984.4%$116.36m
INCYIncyte Corporation
-0.33%68.572.5%$111.36m

Company Profile

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy, and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.